Peer Advisor: Optimal Lipid Management

Please Note: This CME activity has expired. You may continue to view the material for educational purposes, but this activity is no longer eligible for CME credit.

CME Activity Notes:
This activity is part of a Peer Advisor, a series of multimedia CME activities developed with nationally recognized thought leaders in the area of cardiovascular disease, specifically on the role of niacin as a well-established therapy for improving lipid and atherosclerotic parameters and reducing cardiovascular risk factors in patients with lipid disorders.

To view the Peer Advisor in its entirety, please click below.

Course Objectives:
This multimedia CME activity is intended for cardiologists, primary care physicians, and healthcare practitioners who treat patients with lipid disorders. Upon completing this multimedia CME activity, you should be able to:

1. Discuss the beneficial effects of niacin therapy on cardiovascular risk factors.
2. Discuss the long-term safety and efficacy of combination therapy with niacin and statins in reducing cardiovascular risk in patients with dyslipidemia.
3. Discuss the effects of niacin and statin combination therapy on carotid intima-media thickness.
4. Describe flushing associated with niacin therapy and possible management strategies.

Accreditation:
Millennium CME Institute, Inc., is accredited by the ACCME to provide continuing medical education for physicians.

Millennium CME Institute, Inc., designates this educational program for a maximum of 4.0 AMA PRA Category 1 Credit^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity was prepared in accordance with the ACCME Essentials.

This multimedia CME activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Mark A. Gendreau, MD, MS; Nicole Weinreb, MD; and Abigail Zavod, MD.

Release Date: June 2007

Expiration Date: June 30, 2008

© 2007 Millennium CME Institute, Inc. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from Millennium CME Institute, Inc.

Faculty Disclosure:
Millennium CME Institute, Inc., endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. All faculty are required to disclose any commercial relationships or personal benefit with companies whose products are discussed in educational presentations and with companies who have provided the commercial support for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

The faculty listed below have declared the following arrangements and/or affiliations:
William E. Boden, MD, FACC: Honoraria/Consultant — Abbott, Brisol-Myers Squibb, CV Therapeutics, Merck, PDL BioPharma, Pfizer

Richard H. Karas, MD, PhD: Grant/Research Support — Abbott, AstraZeneca; Consultant/Speakers Bureau — Abbott,Merck; Honoraria — Abbott,Merck

Karol E. Watson, MD, PhD, FACC: Honoraria/Consultant — Abbott, AstraZeneca, Merck, Schering-Plough, Sanofi-Aventis

The faculty listed below have declared that they have no relationships to disclose:

• Mark A. Gendreau, MD, MS
• David C. Howard
• Tim I. Robinson
• Nicole Weinreb, MD
• Abigail Zavod, MD

Signed disclosure forms are on file at Millennium CME Institute, Inc.

The opinions expressed in this publication are those of the participating faculty and do not necessarily reflect the opinions or the recommendations of their affiliated institutions; Millennium CME Institute, Inc.; or any other persons. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this publication should not be used by clinicians without evaluation of their patients’ conditions, assessment of possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with the recommendations of other authorities.

Off-label Usage Disclosure
This multimedia CME activity may contain information on commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.

Medical Reviewers

• Mark A. Gendreau, MD, MS Associate Vice Chairman, Senior Staff Physician, Lahey Clinic, Burlington, Massachusetts
• Nicole Weinreb, MD Consulting Physician, Lahey Clinic, Burlington, Massachusetts
• Abigail Zavod, MD, MPH Lahey Clinic, Burlington, Massachusetts

Planning Committee

• Tim I. Robinson President, Millennium CME Institute, Inc., Hampton, New Hampshire
• David C. Howard, BS Pharmacy Director of Clinical Affairs, Millennium CME Institute, Inc., Hampton, New Hampshire

Directions:
For each activity in the multimedia CME program, the learner should read the learning objectives and review the content in its entirety. After reviewing the material, the learner should complete the Activity Self-assessment Test consisting of a series of multiple-choice questions.

Upon successfully completing this activity as designed and achieving a passing score of 70% or higher on the Activity Self-assessment Test, participants will receive a continuing education credit letter awarding the appropriate credit.

Estimated time to complete this activity as designed is 4.0 hours.

CME Testing Options